Dr. Sheng Yang received his doctoral degree in 2000 from the Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS). After completing his doctorate, he began his faculty career at the Institute of Plant Physiology & Ecology at the Shanghai Institutes for Biological Sciences, CAS. Dr. Yang is currently the Director of the Shanghai Research and Dev More...
Biocatalyst engineering, Microbial genome editing, CRISPR/Cas system development
Jing, X., B. Xie, L. Chen, N. Zhang, Y. Jiang, H. Qin, H. Wang, P. Hao, S. Yang, and X. Li. 2018. 'Implementation of the CRISPR-Cas13a system in fission yeast and its repurposing for precise RNA editing', Nucleic Acids Res.
Sun, B., J. Yang, S. Yang, R. D. Ye, D. Chen, and Y. Jiang. 2018. 'A CRISPR-Cpf1-Assisted Non-Homologous End Joining Genome Editing System of Mycobacterium smegmatis', Biotechnol J: e1700588.
Sun, J., Q. Wang, Y. Jiang, Z. Wen, L. Yang, J. Wu, and S. Yang. 2018. 'Genome editing and transcriptional repression in Pseudomonas putida KT2440 via the type II CRISPR system', Microb Cell Fact, 17: 41.
|Cat. No.||Name||Plasmid Copy||Bacterial Resistance||Growth Strain|